Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Pharmacielo Ltd PCLOF


Primary Symbol: V.PCLO

PharmaCielo Ltd. is a Canada-based company with a focus on ethical and sustainable processing and supplying of all natural, pharmaceutical-grade medical cannabis products to channel distributors. The Company has two subsidiaries, PharmaCielo Colombia Holdings S.A.S. (PharmaCielo Colombia) and Ubiquo Telemedicina S.A.S. (Ubiquo). PharmaCielo Colombia cultivates and processes the Company’s all-natural cannabis into standardized, medicinal-grade oil extracts and related products. In Colombia, PharmaCielo Colombia is a licensed cultivator, producer, and distributor of both TetraHydroCannabinol (THC) and Cannabidiol (CBD) medical cannabis for use in Colombia, international export, and research purposes. Ubiquo is a knowledge management and medical consultation system that focuses on creating access to healthcare for Colombians. Ubiquo is a technology platform and a user interface that allows doctors and patients to communicate. Ubiquo is used as a communication tool.


TSXV:PCLO - Post by User

Post by Francine01on Jan 28, 2021 5:20pm
150 Views
Post# 32414396

Something is not adding

Something is not adding Is it me, or something is weird with the yesterday, Jan 27 PR ?

It says that August 13, 2020, 82,626,562 common shares were sold with the ATM, but :

1) 82 M "new shares" are not registred neither on the Nasdaq or TSX. As of today, 96,892,000 shares are listed and not 179,495,705 as written in the PR.

2) SP was around 71cents around August 13, and SP drop to 20 cents in september, buyers had 3 weeks to cash significant profit before T2 negatve results, the timing is very strange.  

2) As of August 2020, T2 results were not disclosed, so why management issued shares at 50% discount compared to market value ?  Management was blinded and still disclosing that they were confident with T2 positive results ?  .. did they had material information that was not communicated to the shareholders ? 

3) Why management did not disclosed in August or September that they issued shares 82 M at 34 cents ? Was it for friends and family ? Why that discount ? 

4) Since September, Management is silent ? what is going on? they have in hands all seconday end points, is it because they need time for the 82 M shares to be liquidate on the market before releasing negative informations .. 

5) The CFO JF Boily left in september, did he left because he was not comfortable with this ? 

I think SEC and AMF should investigate was is going with Jan and Pierre, something is very fishy unless the PR is incorrect ... 
<< Previous
Bullboard Posts
Next >>